Cargando…
Middle East Respiratory Syndrome coronavirus vaccine development: updating clinical studies using platform technologies
Middle East Respiratory Syndrome coronavirus (MERS-CoV), a contagious zoonotic virus, causes severe respiratory infection with a case fatality rate of approximately 35% in humans. Intermittent sporadic cases in communities and healthcare facility outbreaks have continued to occur since its first ide...
Autores principales: | Choi, Jung-ah, Kim, Jae-Ouk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Microbiological Society of Korea
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795722/ https://www.ncbi.nlm.nih.gov/pubmed/35089585 http://dx.doi.org/10.1007/s12275-022-1547-8 |
Ejemplares similares
-
Middle East Respiratory Syndrome Coronavirus: Update for Clinicians
por: Rasmussen, Sonja A., et al.
Publicado: (2015) -
Vaccine against Middle East respiratory syndrome coronavirus
por: Shen, Xuejuan, et al.
Publicado: (2019) -
Vaccine against Middle East respiratory syndrome coronavirus
por: Zumla, Alimuddin, et al.
Publicado: (2019) -
Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus
por: Yong, Chean Yeah, et al.
Publicado: (2019) -
The Middle East respiratory syndrome coronavirus()
por: Reina, Jordi, et al.
Publicado: (2015)